2021
DOI: 10.3390/cancers13051177
|View full text |Cite
|
Sign up to set email alerts
|

Changes in Metabolic Syndrome Status and Breast Cancer Risk: A Nationwide Cohort Study

Abstract: Objective: To our knowledge, no studies have yet looked at how the risk of developing breast cancer (BC) varies with changes in metabolic syndrome (MetS) status. This study aimed to investigate the association between changes in MetS and subsequent BC occurrence. Research Design and Methods: We enrolled 930,055 postmenopausal women aged 40–74 years who participated in a biennial National Health Screening Program in 2009–2010 and 2011–2012. Participants were categorized into four groups according to change in M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 41 publications
2
14
0
Order By: Relevance
“…The studies in [ 5 ] included 148 studies up until 2017 and looked at both studies that had no association and studies that had a positive association. The impact of hypertension on breast, colorectal, and endometrial cancers has also been reported in other studies [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], but the most confirmed association has been made for renal cell carcinoma (RCC) [ 5 , 25 , 26 ]. One study observed the odds ratio (OR) with a 95% confidence ratio in individuals with self-reported hypertension in both men and women and found that hypertension was independently associated with a 40% increased risk of RCC compared to the refenced nonhypertensive patients (OR: 1.4; CI: 1.1–1.9 and OR: 1.0; CI: reference, respectfully) [ 26 ], and this increase was also observed in younger (20–39 years of age) hypertensive patients, where they saw a smaller but significant 16% increase in risk [ 27 ].…”
Section: Introductionmentioning
confidence: 52%
See 3 more Smart Citations
“…The studies in [ 5 ] included 148 studies up until 2017 and looked at both studies that had no association and studies that had a positive association. The impact of hypertension on breast, colorectal, and endometrial cancers has also been reported in other studies [ 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 ], but the most confirmed association has been made for renal cell carcinoma (RCC) [ 5 , 25 , 26 ]. One study observed the odds ratio (OR) with a 95% confidence ratio in individuals with self-reported hypertension in both men and women and found that hypertension was independently associated with a 40% increased risk of RCC compared to the refenced nonhypertensive patients (OR: 1.4; CI: 1.1–1.9 and OR: 1.0; CI: reference, respectfully) [ 26 ], and this increase was also observed in younger (20–39 years of age) hypertensive patients, where they saw a smaller but significant 16% increase in risk [ 27 ].…”
Section: Introductionmentioning
confidence: 52%
“…Moreover, we found that even when adjusting for menopausal status, the association increased for postmenopausal women [ 44 ]. Through our further analysis [ 9 , 11 , 12 , 13 , 14 , 15 , 20 , 21 , 23 ], we saw a significant increase in risk for postmenopausal women, possibly because the present study mostly observed postmenopausal women and only included one study that observed a significant association found between hypertension and breast cancer over the entire sample regardless of menopausal status [ 12 ]. To understand the mechanisms underlying hypertension-caused organ-specific cancer, we here discuss the most vital mechanisms.…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…Subjects with untreated MS can easily develop cardiovascular and cerebrovascular disease, with an increased risk of mortality [ 4 ]. Moreover, several epidemiological and clinical studies support the hypothesis that MS may also be an important etiologic factor for the development and progression of certain types of cancer and for overall cancer mortality [ 5 , 6 , 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%